AMJ

04/25/2026

What should travelers know about cholera risk?

While rare, risk increases with unsafe water, outbreak exposure, and limited access to care.

Early recognition and precautions are key to preventing severe outcomes and transmission.

Discover what this means for travelers:

Cholera risk in travelers is rare but serious. Read more about prevention, vaccination, and clinical management.

04/24/2026

Gut microbiome changes may influence vascular disease risk.

A new review links gut-derived metabolites like TMAO and short-chain fatty acids to atherosclerosis and peripheral artery disease risk.

Find out more on AMJ: https://hubs.la/Q04dp0C50

04/24/2026

Think a cosmetic reaction is just a temporary breakout?

New research shows that nearly 25% lead to lasting skin damage including scarring and persistent pigmentation.

Uncover more of the research: https://hubs.la/Q04dm3LK0

04/22/2026

Why are some disease outbreaks harder to predict than others?

New research suggests forecastability varies by season, pathogen, and population size, meaning some outbreaks may be inherently less predictable.

This could help explain why forecast performance shifts across respiratory virus seasons.

Learn more: https://hubs.la/Q04d4qlJ0

04/22/2026

COPD in never-smokers may be a different disease altogether.

New data point to a unique inflammatory profile.

Explore the findings:

COPD without smoking? New data reveal unexpected symptoms and inflammation patterns. Read more to see what this means for care.

04/22/2026

Phase III data show sustained response with ulixacaltamide in essential tremor.

Findings from American Academy of Neurology (AAN) 2026 support its potential as a durable treatment option.

Learn more about the research:

Ulixacaltamide met the primary endpoint in essential tremor. Read more.

04/21/2026

Stroke outcome prediction may be enhanced by AI-driven analysis of clinical notes.

New findings from American Academy of Neurology (AAN) 2026 highlight the potential of large language models in prognostic assessment.

Learn more about the research:

COPE matched GPT 4.1 for stroke outcome prediction from clinical notes at AAN 2026. Read more.

04/20/2026

Rapid whole genome sequencing delivered likely genetic diagnoses in nearly one quarter of hospitalized adults with unexplained neurologic symptoms.

New data presented at American Academy of Neurology (AAN) 2026 highlight its potential to unlock answers in complex cases and reduce diagnostic uncertainty.

Read more:

Rapid whole genome sequencing identified likely genetic diagnoses in complex neurology inpatients. Read more.

04/19/2026

Does gout inflammation follow a biological clock?

New research suggests it may, unfolding across distinct phases with specific therapeutic windows.

Understanding this timeline could help enable more targeted, phase-specific treatment.

Learn more:

Gout inflammation may unfold in timed phases with distinct treatment windows. Read more about this precision model.

04/19/2026

Is there a link between mRNA COVID-19 vaccines and cancer?

A new case report and review explore a temporal association with hematologic malignancy, while emphasizing that current evidence is limited and not causal.

Researchers call for further large-scale and mechanistic studies.

Uncover more of the findings: https://hubs.la/Q04cFPHd0

04/19/2026

Transcranial magnetic stimulation shows promise as an add-on therapy for PTSD.

New research highlights improved symptom reduction and longer-lasting effects when combined with trauma-focused treatment.

Learn more about the study:

Navigated transcranial magnetic stimulation improved PTSD outcomes in residential care. Read more.

04/17/2026

Most dermatology practices don’t fail clinically - they fail operationally.

In this interview with AMJ, Christopher Tomassian, Founder and CEO of The Dermatology Collective, shares what it really takes to build a successful practice - from avoiding costly early mistakes to staying grounded in evidence-based care.

🔹 Why understanding margins is non-negotiable
🔹 How to grow a practice without compromising clinical standards
🔹 The fine line between social media influence and medical responsibility

Plus, his take on combining energy-based therapies and where AI could reshape dermatology next.

Read the full interview: https://hubs.la/Q04cy1ph0